AMN Healthcare Services AMN

Zacks Investment Research 12 nov

AMN Healthcare (AMN) is well-positioned for growth driven by strong healthcare staffing demand, MSP opportunities, and technology investments, with Nurse and Allied revenues rising 27% in Q3. However, the stock faces headwinds from visa delays affecting international nurse placements, pricing pressures, and weakness in Physician and Technology segments. The company holds a Zacks Rank #3 (Hold) rating despite surging 140.5% year-to-date.

Zacks Investment Research 9 nov

AMN Healthcare Services has been upgraded to Zacks Rank #2 (Buy) due to rising earnings estimates. The company is expected to earn $3.32 per share for fiscal year 2026 with no year-over-year change, but analysts have increased consensus estimates by 7.1% over the past three months. The upgrade positions AMN in the top 20% of Zacks-covered stocks, suggesting potential near-term stock price appreciation.

Zacks Investment Research 5 nov

AMN Healthcare Services reported Q3 earnings of $1.16 per share, significantly beating the consensus estimate of $0.22 per share, representing a 427% earnings surprise. Revenues reached $717.27 million, surpassing estimates by 10.69% compared to $634.5 million year-ago. The company has outperformed the market by 202.9% year-to-date versus the S&P 500's 12.3% gain. However, the stock holds a Zacks Rank #3 (Hold) rating with mixed estimate revisions, suggesting near-term performance in line with the market.

Zacks Investment Research 5 nov

AMN Healthcare reported Q3 2026 revenue of $717.27 million, up 13.1% year-over-year, significantly beating the consensus estimate of $648.01 million by 10.69%. EPS came in at $1.16 versus the estimate of $0.22, representing a 427.27% surprise. The Nurse and Allied Solutions segment drove growth with 27.3% year-over-year revenue increase and substantially exceeded operating income expectations. The stock has gained 30.7% over the past month and currently holds a Zacks Rank #3 (Hold) rating.

Zacks Investment Research 29 oct

SPS Commerce reported Q3 2026 earnings of $1.39 per share, beating consensus estimates of $1.22, with revenues of $197.65 million slightly exceeding expectations. However, the stock has underperformed the market, gaining only -4% year-to-date versus the S&P 500's +13.1% gain. The company received a Zacks Rank #3 (Hold) rating with mixed estimate revisions. Meanwhile, AMN Healthcare Services is expected to report a significant 43.6% year-over-year earnings decline for the same quarter.